PhD position: Regulation of translational recoding in RNA viruses
The research group “Recoding mechanisms in Infections” (REMI) of Dr. Neva Caliskan at the Helmholtz Institute for RNA-based infection research (HIRI) in Würzburg (Germany) is offering a PhD position: “Regulation of translational recoding in RNA viruses”.
The Helmholtz Institute for RNA-based Infection Research (HIRI) has been established in May 2017 as joint venture between the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the Julius Maximilian University of Würzburg (JMU). Located on the Würzburg medical campus, it will be the first research institution worldwide to exclusively address the role of ribonucleic acids (RNAs) in infection processes. Based on these findings, the HIRI will pioneer an integrative approach to exploit the vast potential of RNAs as a diagnostic molecule, target and drug for new strategies to combat infectious diseases. The REMI research group will start in January 2018. www.helmholtz-hzi.de/hiri